Subscribe to Email Alerts
Menu
Subscribe to Email Alerts
Home
About Us
Hemp Explained
CBD Explained
Vision & Purpose
Board of Directors
Our Executive Team
Corporate Governance
Operations
Americas
Europe
Australia
Investor Centre
ASX Announcements
Annual General Meeting
Extraordinary General Meeting
Presentations
Annual and Financial Reports
Shareholder Services
Share Price Information
Equity Plan Rules
Right to Receive Documents
Non-Renounceable Rights Issue Offer
Media Centre
Top Stories
Elixinol Wellness in the News
Media Contact Details
Science & Wellness
Contact Us
Subscribe to Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
ASX Announcements
Annual General Meeting
Extraordinary General Meeting
Presentations
Annual and Financial Reports
Shareholder Services
Share Price Information
Equity Plan Rules
Right to Receive Documents
Non-Renounceable Rights Issue Offer
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
21-May-2019
Updated investor presentation May 2019
14-May-2019
EXL granted New York State CBD Authorization
13-May-2019
Investor Presentation May 2019
7-May-2019
Waiver from Listing Rule 14.7
24-Apr-2019
Cleansing Statement
24-Apr-2019
Appendix 3B
24-Apr-2019
Independent Valuation Report
24-Apr-2019
Elixinol acquires 25% of US based Pet Releaf
23-Apr-2019
Quarterly Report and Appendix 4C
18-Apr-2019
Notice of Annual General Meeting/Proxy Form
Previous
1
2
3
4
5
6
7
Next